Status:
COMPLETED
Exosome Treatment and Hair Growth
Lead Sponsor:
COSMEDICIAN AP SDN BHD
Conditions:
Alopecia Androgenica
Eligibility:
MALE
20-50 years
Phase:
NA
Brief Summary
This study investigates a novel exosome-based plant formulation for treating male pattern baldness (androgenetic alopecia), a condition that affects self-esteem and well-being. Current treatments like...
Eligibility Criteria
Inclusion
- Norwood grade 2-3 androgenic alopecia among male Malaysians.
- Aged between 20 and 50 years.
- Demonstrated the ability to comprehend the study protocol and information provided by the investigators.
- Participants willing to give informed consent.
Exclusion
- Pre-existing thyroid disorders, bleeding disorders, or diabetes.
- Current use of any medical hair treatment.
- Corticosteroid or immunosuppressive drug use.
- Alopecia classified as Norwood scale 1, 4, 5, 6, 7, or cicatricial alopecia.
- Smoking.
Key Trial Info
Start Date :
November 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 28 2023
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT06930326
Start Date
November 1 2022
End Date
June 28 2023
Last Update
April 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xeoul Clinic
Subang Jaya, Selangor, Malaysia, 47500